Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-11-034368
Filing Date
2011-06-28
Accepted
2011-06-28 10:19:49
Documents
1
Period of Report
2011-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1689
  Complete submission text file 0001140361-11-034368.txt   3055
Mailing Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775
Business Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775 972-2-548-6555
BIOCANCELL THERAPEUTICS INC. (Issuer) CIK: 0001451980 (see all company filings)

EIN.: 204630076
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOCANCELL THERAPEUTICS, INC. 8 HARTOM ST. JERUSALEM L3 97775
Business Address
Burgin Jonathan (Reporting) CIK: 0001519448 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-53708 | Film No.: 11934619